论文部分内容阅读
目的观察中西医结合方法治疗缺血性心脏病的疗效。方法将研究对象264例按照住院治疗的先后顺序随机分为观察组和对照组各132例。对照组采用传统治疗方法,观察组在此基础上,加用曲美他嗪和丹红注射液。两组均治疗2个疗程评价疗效,并连续进行病情追踪访视8周。结果观察组整体疗效优于对照组(P<0.05),差异有统计学意义。两组患者治疗前后在心绞痛发作次数、持续时间、硝酸甘油用量、SV、CO、LVEF等主要症状和体征方面缓解与改善方面,观察组明显优于对照组(P<0.05,P<0.01)。结论曲美他嗪和丹红注射液联合应用治疗缺血性心脏病,可提高疗效,具有良好的协同作用。
Objective To observe the curative effect of integrated traditional Chinese and western medicine on ischemic heart disease. Methods 264 cases were randomly divided into observation group and control group according to the order of hospitalization. The control group using the traditional treatment methods, the observation group on this basis, plus trimetazidine and Danhong injection. Two groups were treated 2 courses evaluation efficacy, and continuous follow-up of disease tracking for 8 weeks. Results The overall efficacy of the observation group was better than that of the control group (P <0.05), the difference was statistically significant. Before and after treatment, the observation group was significantly better than the control group (P <0.05, P <0.01) in terms of the number and duration of angina attacks, the amount of nitroglycerin, SV, CO, LVEF and other major symptoms and signs. Conclusion Trimetazidine and Danhong injection combined with ischemic heart disease can improve the curative effect and have good synergistic effect.